Skip to content
AusGrant
Federal Forecasted GRANTS-GOV-356044

Center for Research on Complex Generics (U18) Clinical Trials Optional

Food and Drug Administration (HHS) · Competitive grant · Science & Technology

At a glance

Center for Research on Complex Generics (U18) Clinical Trials Optional is a federal competitive grant from Food and Drug Administration for the science & technology sector. Funding is up to $1.5M. Eligible applicants: Native American tribal governments (Federally recognized); Public and State controlled institutions of higher education; State governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of hi. Applications are accepted on a rolling basis. Apply via the official listing at www.grants.gov.

Amount
Up to $1.5M
Deadline
Rolling
Type
Competitive
Status
Forecasted

About this program

The Food and Drug Administration (FDA) seeks to fund a Center for Research on Complex Generics under the terms and conditions of a cooperative agreement. The Center for Research on Complex Generics will support the FDA's efforts to enhance collaborations with the generic drug industry relating to generic drug research, to further the FDA's mission of increasing patient access to high quality, safe, and effective generic drugs.The goals of a Center for Research on Complex Generics include: 1) Facilitating engagement with generic industry representatives to help identify scientific challenges for generic product development or assessment, and helping to inform FDA about priority areas for research to address these challenges by supporting engagement and coordination between the FDA and key generic industry industry associations, companies, and representatives.2) Providing a forum for experts from FDA, academia, the generic drug industry, and elsewhere to collaborate on research related to generic products.3) Coordinating and conducting research projects pertaining to generic products, particularly complex generics.4) Hosting scientific workshops, providing training, and supporting other educational activities pertaining to generic drug research.5) Providing free and open public access to generic drug research outcomes such as scientific articles, posters, presentations, and other resources that help the generic drug industry to leverage scientific insights from FDA funded generic drug research.The Center for Research on Complex Generics is expected to complement FDA's existing regulatory science programs through its specific focus as a hub for coordination and engagement between FDA and the public, including academic experts, generic industry representatives, and other stakeholders.

Who can apply

Native American tribal governments (Federally recognized); Public and State controlled institutions of higher education; State governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; City or township governments; Native American tribal organizations (other than Federally recognized tribal governments); Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"; Private institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Public housing authorities/Indian housing authorities; Special district governments; Independent school districts; County governments; For profit organizations other than small businesses; Small businesses

How to apply

Apply through Grants.gov using funding opportunity number FOR-FD-25-004. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.

Apply at official source